USPH VS ABCL Stock Comparison

Performance

USPH
100/100

USPH returned 2.89% in the last 12 months. Based on SPY's performance of -13.44%, its performance is above average giving it a score of 100 of 100.

ABCL
10/100

ABCL returned -70.60% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

USPH
61/100

7 analysts offer 12-month price targets for USPH. Together, they have an average target of 0, the most optimistic target put USPH at 0 within 12-months and the most pessimistic has USPH at 0.

ABCL

"Analyst Price Targets" not found for ABCL

Sentiment

USPH
67/100

USPH had a bullish sentiment score of 66.64% across Twitter and StockTwits over the last 12 months. It had an average of 2.88 posts, 0.12 comments, and 0.00 likes per day.

ABCL

"Sentiment" not found for ABCL

Technicals

USPH
50/100

USPH receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.

ABCL
50/100

ABCL receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.

Earnings

USPH
69/100

USPH has missed earnings 2 times in the last 20 quarters.

ABCL
10/100

ABCL has missed earnings 7 times in the last 20 quarters.

Profit

USPH
61/100

Out of the last 20 quarters, USPH has had 20 profitable quarters and has increased their profits year over year on 5 of them.

ABCL
35/100

Out of the last 16 quarters, ABCL has had 6 profitable quarters and has increased their profits year over year on 3 of them.

Volatility

USPH
55/100

USPH has had a higher than average amount of volatility over the last 12 months giving it a score of 54 of 100.

ABCL
39/100

ABCL has had a lower than average amount of volatility over the last 12 months giving it a score of 39 of 100.

Dividend

USPH
19/100

USPH's most recent dividend was $0.82 per share, based on a share price of $87.22. It was a payout ratio of 95.21% compared to their total earnings.

ABCL

"Dividend" not found for ABCL

All score calculations are broken down here to help you make more informed investing decisions

US Physical Therapy Inc Summary

New York Stock Exchange / USPH

Healthcare

Medical - Care Facilities

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

AbCellera Biologics Inc. Common Shares Summary

Nasdaq / ABCL

Healthcare

Biotechnology

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Power up your portfolio